Literature DB >> 11961411

Minimal change nephrotic syndrome developing during postoperative interferon-beta therapy for malignant melanoma.

Kazushi Nakao1, Hitoshi Sugiyama, Eiichi Makino, Hironori Matsuura, Akiko Ohmoto, Taro Sugimoto, Haruo Ichikawa, Jun Wada, Yasushi Yamasaki, Hirofumi Makino.   

Abstract

A 64-year-old man presented with proteinuria during postoperative interferon (IFN)-beta therapy against malignant melanoma. Renal pathologic findings were consistent with minimal change nephrotic syndrome (MCNS) showing extensive foot process effacement of visceral glomerular epithelial cells (podocyte). Nephrotic range proteinuria gradually regressed after stoppage of local injection of IFN-beta without glucocorticoid treatment. To our knowledge this is the first report that demonstrates histological abnormalities of the glomerulus associated with postoperative IFN-beta therapy for the malignant melanoma. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961411     DOI: 10.1159/000054740

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.

Authors:  Glen S Markowitz; Samih H Nasr; M Barry Stokes; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

2.  Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis.

Authors:  Ryuichiro Kumasaka; Norio Nakamura; Kenichi Shirato; Takeshi Fujita; Reiichi Murakami; Michiko Shimada; Masayuki Nakamura; Hiroshi Osawa; Hideaki Yamabe; Ken Okumura
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

3.  Thrombotic microangiopathy associated with use of interferon-beta.

Authors:  Teresa Olea; Raquel Díaz-Mancebo; Maria-Luz Picazo; Jorge Martínez-Ara; Angel Robles; Rafael Selgas
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-06-15

4.  Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?

Authors:  C Yuste; M Rapalai; B A Pritchard; T J Jones; B Tucker; S B Ramakrishna
Journal:  Clin Kidney J       Date:  2014-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.